Profile
Ricky Li Jing Sun is currently a Member of the Board of Directors at Emalex Biosciences, Inc. since 2022, a Director at ADARx Pharmaceuticals, Inc., and a Board Member at Tenacia Biotechnology (Shanghai) Co., Ltd. since 2022.
Former roles include Director-Development & Strategy at Biogen, Inc. from 2013 to 2016, Independent Director at Annexon, Inc. from 2018 to 2022, Independent Director at Arcutis Biotherapeutics, Inc., Independent Director at Savara, Inc. from 2019 to 2024, Director at Beijing Anshi Biological Technology Co., Ltd., Research Analyst at Lehman Brothers, Inc. from 2006 to 2007, Vice President at BlackRock Finance, Inc. from 2012 to 2013, Senior Scientist at Ironwood Pharmaceuticals, Inc. from 2002 to 2004, Analyst at Citadel Enterprise Americas LLC from 2007 to 2009, Research Associate at Morgan Stanley & Co. LLC in 2006, Senior Analyst at Alyeska Investment Group LP from 2010 to 2012, Associate at Lux Capital Management LLC from 2005 to 2006, Research Fellow at Harvard Medical School in 2002, Senior Analyst at BlackRock Financial Management, Inc. from 2012 to 2013, Member-Observer Board at Replimune Group, Inc. from 2017 to 2018, and Board Member at Pharvaris GmbH from 2019 to 2021.
Education includes an MBA from The Leonard N Stern School of Business in 2006, graduate and doctorate degrees from Harvard University in 1998 and 2001 respectively, and an undergraduate degree from Berea College in 1995.
Ricky Sun active positions
| Companies | Position | Start |
|---|---|---|
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Private Equity Investor | 31/07/2016 |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Director/Board Member | - |
Emalex Biosciences, Inc.
Emalex Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for central nervous system disorders | Director/Board Member | 31/10/2022 |
Tenacia Biotechnology (Shanghai) Co. Ltd.
Tenacia Biotechnology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Engages in research and development of treatments for central nervous system disorders | Director/Board Member | 30/04/2022 |
Former positions of Ricky Sun
| Companies | Position | End |
|---|---|---|
| SAVARA INC. | Director/Board Member | 05/06/2024 |
| ANNEXON, INC. | Director/Board Member | 31/01/2022 |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 27/02/2021 |
| REPLIMUNE GROUP, INC. | Corporate Officer/Principal | 30/06/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 30/06/2016 |
Training of Ricky Sun
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 23 |
|---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
BlackRock Finance, Inc.
BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions | Finance |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Citadel Enterprise Americas LLC
Citadel Enterprise Americas LLC Investment ManagersFinance Citadel Enterprise invests in public equity, fixed income and alternative investment markets across the globe. The firm seeks to identify the highest and best uses of capital to generate superior long-term returns for their clients. | Finance |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berea College
Berea College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alyeska Investment Group LP
Alyeska Investment Group LP Investment ManagersFinance Alyeska employs both fundamental and quantitative analysis of publicly traded companies and their respective securities. The firm seeks to generate a consistent, long-term appreciation of assets through the active management of an equity-focused portfolio which includes sector specific, market-neutral sub-portfolios together with various complementary equity-focused investment strategies. They have flexibility to invest in a wide range of listed and OTC equity, equity-linked and credit instruments as well as other asset classes in connection with the fundamental and quantitative strategies that they employ. | Finance |
Lux Capital Management LLC
Lux Capital Management LLC Financial ConglomeratesFinance Operates investment company | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BlackRock Financial Management, Inc.
BlackRock Financial Management, Inc. Investment ManagersFinance BFM utilizes fixed-income strategies that are actively managed, model or index based. The firm generally employs an active investment style that emphasizes rotation among different types of debt on a relative value basis, specific security selection, quantitative analysis of each security and the portfolio as a whole and intensive credit analysis and review. They utilize a risk-controlled, systematic process for portfolio construction and alpha generation. | Finance |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Savara, Inc.
Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Emalex Biosciences, Inc.
Emalex Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for central nervous system disorders | Health Technology |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Beijing Anshi Biological Technology Co., Ltd.
Beijing Anshi Biological Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in research, development and commercialization on cancer treatment | Health Technology |
Tenacia Biotechnology (Shanghai) Co. Ltd.
Tenacia Biotechnology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Engages in research and development of treatments for central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Ricky Sun
















